North China Pharmaceutical Company.,Ltd.’s Net Profit Rose 295% in First Half of 2022

North China Pharmaceutical Company.,Ltd. (华北制药股份有限公司) (600812.SH) reported a net profit of 43.5 million yuan in the first half of 2022, up 295% year-on-year.

Meanwhile, the company posted 5.3 billion yuan in revenue, down 5.5% year-on-year.

At the end of the reporting period, it had 25.3 billion yuan in total assets and 18.3 billion yuan in total liabilities, with a liability-to-asset ratio of 72.5%.